DailyDoctor Archive Specialties Get app
Back to the 26 September 2026 edition

Research · 03 of 06

Esketamine-containing regimens were associated with less delirium in older surgical patients

Esketamine may reduce delirium in older surgical patients, but the evidence is not yet strong enough to use it for that reason alone.

Design
Systematic review and meta-analysis of randomised trials
Population
17 trials, 2,914 surgical patients aged 60 and over
Primary outcome
Postoperative delirium incidence
Effect
OR 0.57 (95% CI 0.40 to 0.82); PONV OR 0.49 (0.32 to 0.75)

This meta-analysis, published 14 September in BMC Geriatrics, pooled 17 randomised trials with 2,914 adults aged 60 and over given perioperative esketamine-containing regimens; 11 trials contributed to the primary delirium analysis.

Esketamine was associated with lower postoperative delirium (OR 0.57, 95% CI 0.40 to 0.82; I² 45.8%) and less nausea and vomiting (OR 0.49), without more psychiatric adverse events (OR 1.41, 0.67 to 2.96). Four trials suggested less postoperative cognitive dysfunction (OR 0.39), but certainty was very low. There was no dose–response relationship.

Most trials were from single centres with varied anaesthetic and analgesic regimens, and esketamine is not available everywhere. The signal is consistent enough to justify larger standardised trials, not yet to add esketamine for delirium prevention alone.

  • Esketamine-containing regimens were associated with less delirium in patients over 60.
  • They were also associated with less postoperative nausea and vomiting.
  • No increase in psychiatric adverse events was seen, although the confidence interval was wide.
  • Continue proven delirium prevention — orientation, sleep, avoiding benzodiazepines — as the foundation.

Why it matters

Adds a possible pharmacological lever to delirium prevention, which has few.

Don't overread it

Mostly small single-centre trials with varied co-interventions; the review was registered retrospectively.

The statistics, in plain English

An odds ratio of 0.57 suggests about 40% lower odds of delirium. Moderate heterogeneity (I² 46%) means trials differed, and the very-low-certainty cognitive result should not be quoted as established.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

perioperativeairwaymgmtgeneralanaes

Tomorrow morning, before your first patient

One edition a day for anaesthesiology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app